Abstract
Mutations in Methyl-CpG-Binding protein 2 (MECP2) are commonly associated with the neurodevelopmental disorder Rett syndrome (RTT). However, some people with RTT do not have mutations in MECP2, and interestingly there have been people identified with MECP2 mutations that do not have the clinical features of RTT. In this report we present four people with neurodevelopmental abnormalities and clear RTT-disease causing MECP2 mutation but lacking the characteristic clinical features of RTT. One patient’s symptoms suggest an extension of the known spectrum of MECP2 associated phenotypes to include global developmental delay with obsessive compulsive disorder and attention deficit hyperactivity disorder. These results reemphasize that RTT should remain a clinical diagnosis, based on the recent consensus criteria.
References
Allen, R. C., Zoghbi, H. Y., Moseley, A. B., Rosenblatt, H. M., & Belmont, J. W. (1992). Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. American Journal of Human Genetics, 51(6), 1229–1239.
Amir, R. E., Van den Veyver, I. B., Wan, M., Tran, C. Q., Francke, U., & Zoghbi, H. Y. (1999). Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nature Genetics, 23(2), 185–188. doi:10.1038/13810.
Bebbington, A., Anderson, A., Ravine, D., Fyfe, S., Pineda, M., de Klerk, N., et al. (2008). Investigating genotype-phenotype relationships in Rett syndrome using an international data set. Neurology, 70(11), 868–875. doi:10.1212/01.wnl.0000304752.50773.ec.
Bebbington, A., Percy, A., Christodoulou, J., Ravine, D., Ho, G., Jacoby, P., et al. (2010). Updating the profile of C-terminal MECP2 deletions in Rett syndrome. Journal of Medical Genetics, 47(4), 242–248.
Beyer, K. S., Blasi, F., Bacchelli, E., Klauck, S. M., Maestrini, E., & Poustka, A. (2002). Mutation analysis of the coding sequence of the MECP2 gene in infantile autism. Human Genetics, 111(4–5), 305–309. doi:10.1007/s00439-002-0786-3.
Bittel, D. C., Theodoro, M. F., Kibiryeva, N., Fischer, W., Talebizadeh, Z., & Butler, M. G. (2008). Comparison of X-chromosome inactivation patterns in multiple tissues from human females. Journal of Medical Genetics, 45(5), 309–313. doi:10.1136/jmg.2007.055244.
Carney, R. M., Wolpert, C. M., Ravan, S. A., Shahbazian, M., Ashley-Koch, A., Cuccaro, M. L., et al. (2003). Identification of MeCP2 mutations in a series of females with autistic disorder. Pediatric Neurology, 28(3), 205–211.
Chahrour, M., & Zoghbi, H. Y. (2007). The story of Rett syndrome: From clinic to neurobiology. Neuron, 56(3), 422–437. doi:10.1016/j.neuron.2007.10.001.
Corbani, S., Chouery, E., Fayyad, J., Fawaz, A., El Tourjuman, O., Badens, C., et al. (2012). Molecular screening of MECP2 gene in a cohort of Lebanese patients suspected with Rett syndrome: Report on a mild case with a novel indel mutation. Journal of Intellectual Disability Research, 56(4), 415–420. doi:10.1111/j.1365-2788.2011.01479.x.
Gibson, J. H., Williamson, S. L., Arbuckle, S., & Christodoulou, J. (2005). X chromosome inactivation patterns in brain in Rett syndrome: Implications for the disease phenotype. Brain and Development, 27(4), 266–270.
Harvey, C. G., Menon, S. D., Stachowiak, B., Noor, A., Proctor, A., Mensah, A. K., et al. (2007). Sequence variants within exon 1 of MECP2 occur in females with mental retardation. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 144B(3), 355–360. doi:10.1002/ajmg.b.30425.
Huppke, P., Held, M., Laccone, F., & Hanefeld, F. (2003). The spectrum of phenotypes in females with Rett Syndrome. Brain and Development, 25(5), 346–351.
Kaufmann, W. E., Tierney, E., Rohde, C. A., Suarez-Pedraza, M. C., Clarke, M. A., Salorio, C. F., et al. (2011). Social impairments in Rett syndrome: Characteristics and relationship with clinical severity. Journal of Intellectual Disability Research, 56(3), 233–247. doi:10.1111/j.1365-2788.2011.01404.x.
Kleefstra, T., Yntema, H. G., Nillesen, W. M., Oudakker, A. R., Mullaart, R. A., Geerdink, N., et al. (2004). MECP2 analysis in mentally retarded patients: Implications for routine DNA diagnostics. European Journal of Human Genetics, 12(1), 24–28.
Neul, J. L. (2012). The relationship of Rett syndrome and MECP2 disorders to autism. Dialogues in Clinical Neuroscience, 14(3), 253–262.
Neul, J. L., Fang, P., Barrish, J., Lane, J., Caeg, E. B., Smith, E. O., et al. (2008). Specific mutations in methyl-CpG-binding protein 2 confer different severity in Rett syndrome. Neurology, 70(16), 1313–1321. doi:10.1212/01.wnl.0000291011.54508.aa.
Neul, J. L., Kaufmann, W. E., Glaze, D. G., Christodoulou, J., Clarke, A. J., Bahi-Buisson, N., et al. (2010). Rett syndrome: Revised diagnostic criteria and nomenclature. Annals of Neurology, 68(6), 944–950. doi:10.1002/ana.22124.
Neul, J. L., & Zoghbi, H. Y. (2004). Rett syndrome: A prototypical neurodevelopmental disorder. Neuroscientist, 10(2), 118–128. doi:10.1177/1073858403260995.
Olsson, B., & Rett, A. (1987). Autism and Rett syndrome: Behavioural investigations and differential diagnosis. Developmental Medicine and Child Neurology, 29(4), 429–441.
Percy, A. K., Neul, J. L., Glaze, D. G., Motil, K. J., Skinner, S. A., Khwaja, O., et al. (2010). Rett syndrome diagnostic criteria: Lessons from the Natural History Study. Annals of Neurology, 68(6), 951–955. doi:10.1002/ana.22154.
Percy, A. K., Zoghbi, H. Y., Lewis, K. R., & Jankovic, J. (1988). Rett syndrome: Qualitative and quantitative differentiation from autism. Journal of Child Neurology, 3(Suppl), S65–S67.
Shahbazian, M. D., & Zoghbi, H. Y. (2001). Molecular genetics of Rett syndrome and clinical spectrum of MECP2 mutations. Current Opinion in Neurology, 14(2), 171–176.
Shevell, M., Ashwal, S., Donley, D., Flint, J., Gingold, M., Hirtz, D., et al. (2003). Practice parameter: Evaluation of the child with global developmental delay: Report of the Quality Standards Subcommittee of the American Academy of Neurology and The Practice Committee of the Child Neurology Society. Neurology, 60(3), 367–380.
Trevathan, E., & Naidu, S. (1988). The clinical recognition and differential diagnosis of Rett syndrome. Journal of Child Neurology, 3(Suppl), S6–S16.
Watson, P., Black, G., Ramsden, S., Barrow, M., Super, M., Kerr, B., et al. (2001). Angelman syndrome phenotype associated with mutations in MECP2, a gene encoding a methyl CpG binding protein. Journal of Medical Genetics, 38(4), 224–228.
Ylisaukko-Oja, T., Rehnstrom, K., Vanhala, R., Kempas, E., von Koskull, H., Tengstrom, C., et al. (2005). MECP2 mutation analysis in patients with mental retardation. American Journal of Medical Genetics A, 132A(2), 121–124. doi:10.1002/ajmg.a.30416.
Young, D. J., Bebbington, A., Anderson, A., Ravine, D., Ellaway, C., Kulkarni, A., et al. (2008). The diagnosis of autism in a female: Could it be Rett syndrome? European Journal of Pediatrics, 167(6), 661–669. doi:10.1007/s00431-007-0569-x.
Acknowledgments
JLN is supported by the Petrello Scholar Endowment, Jan and Dan Duncan Neurological Institute, Texas Children’s Hospital. The work was supported by HD040301.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Suter, B., Treadwell-Deering, D., Zoghbi, H.Y. et al. Brief Report: MECP2 Mutations in People Without Rett Syndrome. J Autism Dev Disord 44, 703–711 (2014). https://doi.org/10.1007/s10803-013-1902-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10803-013-1902-z